Clinical Trial: Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923487) titled 'Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury' on Nov. 02.

Brief Summary: This study is a pilot single arm, Phase 1b study of the safety and preliminary efficacy of PSC-05, an adipose-derived autologous mesenchymal stem cell for the treatment of chronic mTBI. This study will focus on United States military special forces operators.

Study Start Date: Nov. 01

Study Type: INTERVENTIONAL

Condition: Mild Traumatic Brain Injury

Intervention: BIOLOGICAL: autologous adipose-derived stem cells

culture-expanded adipose stem cells

Recruitment Status: ENROLLING_BY_INVITATION

Spo...